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Hepatocyte growth factor/scatter factor (HGF/SF) has
recently been shown to stimulate the hair follicle growth
of mouse vibrissae in vitro. In this study, we analyzed the
effect of cutaneous injections of recombinant human
HGF/SF on hair follicle growth using mice in different
hair cycle stages. Five male newborn mice, five male
mice in second anagen, and five male mice in second
telogen were administered a dorsal intradermal injection
of 1 mg HGF/SF dissolved in 0.1% albumin-phosphate-
buffered saline once daily for five or seven consecutive
days, and then sacrificed on days 7 or 10. Hair follicle
growth was evaluated photometrically and histologically
using three parameters: the skin color of the reverse side
of the resected skin, the skin thickness, and the area
occupied by hair follicle tissue. The HGF/SF injected skin
Hepatocyte growth factor/scatter factor (HGF/SF) is amultifunctional heterodimeric polypeptide originallyidentified as a mitogen for hepatocytes (for review seeRubin et al, 1993; Matsumoto and Nakamura, 1994;Zarnegar and Michalopoulos, 1995). HGF/SF has
been thought to be secreted by mesenchymally derived cells and to
function as a paracrine factor on neighboring epithelial or endothelial
cells. Mitogenic, motogenic, and morphogenic activities of HGF/SF
vary with the target cells and experimental conditions.
We recently reported that HGF/SF stimulated the hair follicle
growth of mouse vibrissae (Jindo et al, 1994) and human scalp hairs
(Jindo et al, 1995) in an organ culture system. We subsequently
reported that HGF/SF stimulated DNA synthesis of hair bulb derived
keratinocytes with the strongest response at 30 ng HGF/SF per ml
(Shimaoka et al, 1995). Furthermore, HGF/SF expressed in cultured
follicular papilla cells was upregulated in response to interleukin
(IL)-1α and tumor necrosis factor (TNF)-α (Shimaoka et al, 1995).
For a series of experiments clarifying the stimulatory effect of
HGF/SF on hair growth, we designed an in vivo experiment using
mice having well-known hair cycles. Because the molecular size of
HGF/SF is too large to be absorbed from the skin surface, dissolved
HGF/SF was injected intradermally to the dorsal skin on consecutive
days. Hair follicle growth was evaluated photometrically and histo-
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of newborn mice had hair follicles that were histologically
longer and larger than those of the 0.1% albumin-
phosphate-buffered saline injected skin. Mice that had
received HGF/SF injection in second anagen, retained
anagen hair follicles after 10 d only at the injection site,
suggesting that HGF/SF delayed the transition from
anagen to telogen. The HGF/SF injected skin of telogen
mice had a significant increase in hair follicle tissue in
the dermis, suggesting a mild anagen inducible activity
by HGF/SF. Furthermore, precise measurements of the
20 hairs plucked from the HGF/SF injection sites revealed
mild hair elongation in all the aforementioned experi-
ments. These results imply that HGF/SF acts as a para-
crine factor that alters cyclic hair growth of mice. Key
words: hair cycle/hair growth/mouse. J Invest Dermatol
110:338–342, 1998
logically. To examine the anagen-preservable and anagen-inducible
activities of HGF/SF, mice in second anagen and second telogen, as
well as newborn mice, were used for the experiments. Basic fibroblast
growth factor (bFGF), which is known to retard hair development in
neonatal mice (du Cros, 1993), was also examined for comparison.
MATERIALS AND METHODS
Reagents Recombinant human HGF/SF (five amino acids-deleted form)
was donated by Snow Brand Milk Products (Tokyo, Japan) (Shima et al, 1991).
Recombinant human bFGF was purchased from R&D Systems (Minneapolis,
MN). These reagents were dissolved in sterile and toxin-free phosphate-buffered
saline containing 0.1% bovine serum albumin (0.1% BSA-PBS) (Sigma, St.
Louis, MO).
Animals and treatment Animals used in this study were obtained from
Japan SLC (Hamamatsu, Japan), and maintained on a standard laboratory diet
and water ad libitum. The experimental design of this study was approved by
the appropriate ethical committee on animal study in Juntendo University. The
mice hairs were neither clipped nor shaved except for the experiment that
measured hair elongation in clipped second telogen mice. Male B6C3F1 mice
(F1: C57BL6 3 C3H, 1 d old; body weight, 1.4–1.5 g) were administered a
dorsal intradermal injection of 1 µg HGF/SF or bFGF dissolved in 50 µl of
0.1% BSA-PBS once daily for 5 d (total 5 µg). All mice were sacrificed on day
7, and one skin sample per mouse was prepared. In other experiments, 29 d
old male C3H mice (second anagen phase; body weight, 16.6–21.2 g) and
45 d old male C3H mice (second telogen phase; body weight, 22.2–25.4 g)
were administered a dorsal intradermal injection of 1 µg HGF/SF or bFGF in
50 µl of 0.1% BSA-PBS once daily for 7 d (total 7 µg), and then sacrificed on
day 10. Control mice of the same age were injected with 50 µl of 0.1% BSA-
PBS once daily for 5 or 7 d. Each mouse received one treatment only, and
each treated group consisted of five mice from different litters.
Evaluation The effect of the local injection of HGF/SF on hair follicle
growth was analyzed photometrically and histologically. The skin color of the
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Figure 1. Local injection of HGF/SF promoted hair follicle growth in newborn mice. HGF/SF, bFGF, or vehicle solution (0.1% BSA-PBS) was injected
intradermally into 1 d old B6C3F1 mice for 5 d (total 5 µg). The mice were sacrificed on day 7, and the effect of the reagents on hair follicle growth assessed as
described in Materials and Methods using three parameters: (A) skin color, (B) skin thickness, and (C) hair follicle tissue. Data are expressed as mean 6 SD of five
mice. * p , 0.05, **p , 0.01.
Figure 2. The HGF/SF injected newborn mouse had histologically
longer and larger hair follicles. Histologic sections typical from the data
summarized in Fig 1 are shown: (A) 0.1% BSA-PBS; (B) HGF/SF
(1 µg 3 5 d); (C) bFGF (1 µg 3 5 d). Scale bar, 0.5 mm.
reverse side of the resected murine skin was measured three times in the
proximity of the injection site within a 8 mm diameter field by a Minolta
Chroma Meter (CR-300, Minolta, Tokyo, Japan) (Queille-Roussel et al, 1991).
The luminance measured reflects the relative darkness ranging from white (0)
to black (100). The darkness of the reverse side of murine skin varied due to
the increase in the melanization of the hair follicle. The skin sample resected
from the injection site was then fixed in 10% buffered formalin solution and
paraffin embedded. A 4 µm thick section was stained with hematoxylin and
Figure 3. Local injection of HGF/SF prolonged the second anagen.
HGF/SF, bFGF, or vehicle solution (0.1% BSA-PBS) was injected intradermally
into 29 d old male C3H mice (the second anagen) for 7 d (total 7 µg), and
then the mice were sacrificed on day 10. The photographs shown are the
reverse side of the resected murine skin: (A) 0.1% BSA-PBS; (B) HGF/SF
(1 µg 3 7 d); (C) bFGF (1 µg 3 7 d). The arrowheads indicate the injection sites.
eosin, and then analyzed histologically by an image analyzer (Mac scope, Mitani,
Fukui, Japan). Skin thickness, which has been shown to correspond to hair
follicle length (Andreasen, 1953), was defined as the distance from the epidermal
granular layer to the top edge of the panniculus carnosus. Measurements were
carried out in three fields, and their average value per mouse was expressed in
millimeters. The size of the hair follicle was estimated by considering the
histologic area occupied by the hair follicles per 1 mm2 field of the dermis and
subcutaneous tissue. Measurements were carried out in three fields, and their
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Figure 4. Local injection of HGF/SF delayed the transition from anagen to telogen. The results shown in Fig 3 were quantitatively analyzed using the
same methods as described in Fig 1: (A) skin color, (B) skin thickness, and (C) hair follicle tissue. Data are expressed as mean 6 SD of five mice. *p , 0.05,
**p , 0.01.
average values expressed in millimeters squared. In order to examine the effect
of HGF/SF on hair length, hairs in the proximity of the injection site were
plucked by forceps under a stereoscopic microscope, and their length measured
by a micrometer. To confirm that the hairs had been plucked in their entirety,
the morphology of every hair tip was checked under a stereoscopic microscope.
The average length of the 20 plucked hairs was expressed in millimeters.
Statistical analysis The data from the tested groups were compared with
those of the 0.1% BSA-PBS injected group, and analyzed by Student’s unpaired
t test. Results were expressed as mean 6 SD.
RESULTS
Local injection of HGF/SF promoted hair follicle growth in
newborn mice Male B6C3F1 mice generally produced black hairs
and dark skin at the age of 5 d. Intradermal injection of HGF/SF or
0.1% BSA-PBS for five consecutive days did not produce any macro-
scopic change; however, injection of bFGF produced a pale and
sclerotic skin appearance and fewer hairs (data not shown). Histologic
sections at the injection sites were prepared, and hair follicle growth
evaluated quantitatively using the three parameters illustrated in Fig 1.
As defined in Materials and Methods, the relative darkness of the reverse
side of the resected skin corresponds to the increase in melanization
of the hair follicle, the skin thickness corresponds to hair follicle length,
and hair follicle tissue corresponds to the area occupied by the hair
follicles. As shown in Fig 1(A), skin darkness (white, 0; black, 100)
was significantly suppressed in bFGF injected mice (p , 0.01), whereas
that of HGF/SF injected mice was not affected. When compared with
BSA-PBS injected mice, the skin of HGF/SF injected mice showed a
slight increase in skin thickness and a significant increase in hair follicle
tissue (p , 0.05) (Fig 1B, C). In contrast, the skin of bFGF injected
mice showed a significant decrease both in skin thickness (p , 0.05)
and in hair follicle tissue (p , 0.05) (Fig 1B, C). Figure 2 shows
histologic sections typical of those summarized in Fig 1. HGF/SF
treated skin (Fig 2B) had longer and larger hair follicles than 0.1%
BSA-PBS treated skin. bFGF treated skin had many immature hair
follicles and an increase in connective tissue under the panniculus
carnosus. The thickness of the dermal and subcutaneous tissues varied
with hair follicle length (Fig 2A–C). The data shown in Figs 1 and
2 were found to be reproducible in two other smaller sized experiments.
Moreover, significantly increased skin thickness and hair follicle tissue
(p , 0.05) were observed when five newborn rats were treated with
1 µg HGF/SF daily for five consecutive days (data not shown).
Local injection of HGF/SF into anagen mice delayed the
transition from anagen to telogen Positive results in newborn
mice led us to examine further the effect of HGF/SF on cyclic hair
growth in adult mice. A preliminary experiment confirmed that 29 d
old male C3H mice are generally in the second anagen, and 10 d later
they are in the second telogen. Accordingly, HGF/SF, bFGF, or vehicle
solution (0.1% BSA-PBS) was injected intradermally into 29 d old
mice for seven consecutive days (total 7 µg), and the mice were then
sacrificed on day 10. The results were analyzed using the same methods
as described for newborn mice, and are illustrated in Figs 3–5. When
HGF/SF was injected intradermally, a striking result was observed on
day 10 (Fig 3B). The areas in close proximity to the injection site of
Figure 5. The HGF/SF injected anagen mouse retained histologically
anagen hair follicles. Histologic sections typical from the data summarized in
Fig 4 are shown: (A) 0.1% BSA-PBS; (B) HGF/SF (1 µg 3 7 d); (C) bFGF
(1 µg 3 7 d). Scale bar, 0.5 mm.
all five mice were still dark in color, and therefore in anagen, whereas
the remaining areas of the HGF/SF treated mice and the injection
sites of the 0.1% BSA-PBS treated mice were pale in color, suggesting
that they were in telogen. These data are supported by the quantitative
analyses shown in Fig 4. The skin of HGF/SF injected mice was dark
in color (p , 0.01), and was thicker and had a larger amount of hair
follicle tissue (p , 0.05). A typical histologic section (Fig 5B) clearly
demonstrates that the HGF/SF treated skin had anagen hair follicles,
though the number of hair follicles was less than that of regular skin
in anagen. In contrast, the areas around the bFGF injected site had
teleangiectasia, probably due to the angiogenetic activity of bFGF
(Fig 3C). One mouse in the bFGF treated group was found to be in
anagen phase rather than second telogen, due to the variation in hair
cycle of individual animals (Fig 3C). Quantitative analyses revealed
that the skin thickness of four bFGF treated mice had significantly
increased (p , 0.01) (Fig 4B) due to the increased connective tissue
with many mononucleated cells in the dermis and subcutaneous
tissue (Fig 5C). The control site injected with 0.1% BSA-PBS was
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Figure 6. Local injection of HGF/SF into telogen mice increased the size of hair follicles. HGF/SF, bFGF, or vehicle solution (0.1% BSA-PBS) was
injected intradermally into 45 d old male C3H mice (the second telogen) for 7 d (total 7 µg), and the mice were then sacrificed on day 10. The results were
quantitatively analyzed using the same methods as described in Fig 1: (A) skin color, (B) skin thickness, and (C) hair follicle tissue. Data are expressed as mean
6 SD of five mice. *p , 0.05, **p , 0.01.
Figure 7. The HGF/SF injected telogen mouse had histologically larger
hair follicles. Typical histologic sections from the data summarized in Fig 6
are shown: (A) 0.1% BSA-PBS; (B) HGF/SF (1 µg 3 7 d); (C) bFGF
(1 µg 3 7 d). Scale bar, 0.5 mm.
indistinguishable from the surrounding skin for all parameters (data
not shown).
Local injection of HGF/SF into telogen mice exhibited a mild
anagen inducible activity Subsequently, induction of anagen hairs
by HGF/SF injection was examined using mice in telogen. HGF/SF,
bFGF, or vehicle solution (0.1% BSA-PBS) was injected intradermally
into 45 d old male C3H mice (second telogen) for seven consecutive
days (total 7 µg), and the mice were then sacrificed on day 10.
Macroscopic and photometric observation did not reveal any anagen-
inducible activity by HGF/SF; however, microscopic analysis pointed
out a significant increase in hair follicle tissue (p , 0.01) (Fig 6C).
HGF/SF injected mice (Fig 7B) had histologically larger hair follicles
in the dermis than those of 0.1% BSA-PBS injected mice, although
they were not complete anagen hair follicles. The same study using
male C3H mice in late second telogen (86 d old) was then carried
out, and the results obtained were almost identical with the data
described above (data not shown). The effect of a local administration
of bFGF on murine skin in telogen was the same as that observed in
anagen skin. bFGF treatment increased the skin thickness (Fig 6B),
which was caused by an increase in cell infiltration and connective
tissue in the dermis and subcutaneous tissue (Fig 7C).
Local injection of HGF/SF slightly elongated the hair
length Because no macroscopic increase in hair number or length
was observed upon HGF/SF injection, precise measurements of the
hair shaft at the HGF/SF injection sites were carried out by measuring
the plucked hair length. The HGF/SF was injected for 7 d into
newborn mice (1 d old), second anagen mice (29 d old), second
telogen mice (45 d old), and clipped second telogen mice (45 d old),
and, 10 d later, 20 hairs were collected from each of the five mice of
each group. As shown in Fig 8, hairs collected from the HGF/SF
injected mice were slightly longer for all four different conditions than
those collected from the 0.1% BSA-PBS injected mice or from the
noninjected sites of the treated mice; however, no statistical significance
was observed due to the variation in individual hair length.
DISCUSSION
Recently, particular families of cytokines and growth factors have been
reported to be involved in the regulation of hair morphogenesis and
cyclic hair growth (for review see Messenger, 1993; Stenn et al, 1994).
Such factors include epidermal growth factor, transforming growth
factor-α, transforming growth factor-β, FGF-1 (acidic FGF), FGF-2
(bFGF), FGF-5, FGF-7 (keratinocyte growth factor, KGF), insulin-
like growth factor-I, IL-1α, and HGF/SF. The influence of these
molecules on hair growth has been demonstrated by immunohisto-
chemical studies, external administration of the proteins, and phenotypic
observation of the mice with a targeted gene deletion or overexpression.
The external administration of such growth factors was initially expected
to stimulate hair growth in vivo; however, epidermal growth factor
(Moore et al, 1983) and bFGF (du Cros, 1993) were reported as
retarding hair growth in animal models. A recent study has reported
that subcutaneous injections of KGF at a daily dose of 5 µg per gram
of body weight for 13 or 17 consecutive days stimulated hair growth
in athymic nude mice, and when administered by intraperitoneal
injection protected cytosine arabinoside-induced alopecia in neonatal
rat (Danilenko et al, 1995). In this study, we demonstrated that a
growth factor named HGF/SF alters the hair cycle and slightly increases
the hair length in normal mice when 1 µg of the protein was
administered intradermally for five or seven consecutive days. Although
the amount of hair elongation was not to the level of that stimulated
by chemical reagents such as FK506 and cyclosporin A, it is worth
noting that a direct growth regulatory ligand influenced hair growth.
Unlike human hairs, murine hair coat has a synchronized hair cycle.
Anagen in mice can easily be distinguished from telogen by skin color,
skin thickness, and the amount of melanogenesis-related proteins
(Andreasen, 1953; Slominski et al, 1991). We previously reported that
the skin color of C3H mice in telogen (milky pink) became zonally
dark (gray to black) when a hair growth stimulatory reagent was locally
applied (Hattori and Ogawa, 1983). To test the effect of HGF/SF
in vivo, we initially used this method; however, macroscopic observation
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Figure 8. Local injection of HGF/SF slightly elongated the hair length. HGF/SF (1 µg) was injected intradermally into four different groups of mice for
7 d (total 7 µg), and all mice were sacrificed on day 10. Twenty hairs in the proximity of the injection site were plucked, and their length measured by a
micrometer. (A) newborn mice (1 d old); (B) second anagen mice (29 d old); (C) second telogen mice (45 d old); (D) clipped second telogen mice (45 d old).
Data are expressed as mean 6 SD of five mice.
after the intradermal injection did not reveal any significant increase
in skin pigmentation or hair length. We therefore performed accurate
evaluations by measuring the color of the reverse side of the resected
murine skin, the histologic skin thickness and hair follicle tissue, and
the exact length of the plucked hairs. The color of the reverse side of
the skin reflects the increase in melanization in anagen, and the two
histologic parameters reflect the size of each hair follicle. We were not
able to monitor the hair length of the living mice due to the thinness
of the hair shafts and their high density.
We clearly demonstrated that HGF/SF has anagen-preservable and
mild anagen-inducible activities, which resulted in mild hair elongation.
Although we could not test the effect of higher doses of HGF/SF due
to its limited supply, 1 µg HGF/SF per ml appeared to be sufficient
to produce effects on hair follicle growth, with our in vitro study
showing that the effect of HGF/SF in cultured cells and organ culture
plateaued at a dose of 10–30 ng per ml. The reliability of the findings
in this study was ensured by repeating the experiments and by
the negative effects induced by the administration of bFGF in a
simultaneously performed experiment (du Cros, 1993). Our previous
data indicated that HGF/SF mRNA is expressed in single human
anagen hair follicles (Mitsui et al, 1997) and in cultured follicular papilla
cells (Shimaoka et al, 1995); however, the level of immunoreactive
HGF/SF protein secreted from cultured follicular papilla cells was not
high (Shimaoka et al, 1995). A circulating inactive form of HGF/SF and
papilla cells-secreted HGF/SF may bind to heparin in the extracellular
matrix, and further to the HGF/SF receptor (c-Met) on the hair
matrix cells after processing by the proteinases. HGF/SF stimulated
keratinocyte growth (Sato et al, 1995) and DNA synthesis of hair bulb
derived keratinocytes (Shimaoka et al, 1995); however, the mitogenic
activity of HGF/SF on keratinocytes appeared to be significantly milder
than that of KGF (Sato et al, 1995), and only HGF/SF revealed hair
follicle growth stimulatory activity in organ culture among numerous
growth factors, including KGF, insulin-like growth factor-I, and
transforming growth factor-α (Jindo et al, 1994). These results imply
that the effect of HGF/SF on hair follicle growth is mainly due to its
morphogenic activity for epithelial cells (Rubin et al, 1993; Matsumoto
and Nakamura, 1994; Zarnegar and Michalopoulos, 1995). Further
in vivo studies to examine the effect of HGF/SF, reconstituted in
liposome or transfersome to cross skin barriers, are now in progress in
order to evaluate the clinical utility of HGF/SF as a hair growth
stimulant.
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